04:37 PM EST, 02/10/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) reported a fiscal Q1 net loss late Monday of $1.39 per diluted share, wider than a $1.24 loss a year earlier.

Analysts polled by FactSet expected a loss of $0.41.

Revenue for the quarter ended Dec. 31 was $2.5 million, compared with $3.6 million a year earlier.

Analysts polled by FactSet expected $72.8 million.

Shares of the company fell 1.9% in recent after-hours activity.

Price: 19.55, Change: -0.37, Percent Change: -1.86